Literature DB >> 27882446

Impact of the size and number of swollen joints on serum C-reactive protein level and erythrocyte sedimentation rate in rheumatoid arthritis: a cross-sectional study in Japan.

Kota Shimada1, Akiko Komiya2, Naoto Yokogawa3, Jinju Nishino4, Shoji Sugii3, Shigeto Tohma5.   

Abstract

No studies have yet reported the influence of swelling in individual joints on serum C-reactive protein and erythrocyte sedimentation rate. To examine this association, we used data from the NinJa registry, the largest registry of rheumatoid arthritis patients in Japan. Sixty-six palpable joints were categorized by size into three groups (small, medium-sized, and knees) with surface area cutoffs of 10 and 100 cm2. Of 10,720 cases registered in NinJa in 2012, 8444 cases with either no swollen joints or swelling limited to one joint-size category were analyzed. Groups with larger numbers of swollen joints showed higher levels of both markers in each joint-size category. Groups with larger swollen joints had higher levels of both markers compared with groups with the same number of (smaller) swollen joints. Linear regression revealed that the increments of C-reactive protein (mg/dL/joint) and erythrocyte sedimentation rate (mm/1 h/joint) were 0.056 and 0.89, 0.24 and 5.0, and 0.46 and 8.9 for small and medium-sized joints and knee joints, respectively. The levels of systemic inflammation markers increased with the involvement of larger and/or more joints. These results were successfully illustrated by the use of large-scale data, which eliminated wide intragroup scattering of the marker values.

Entities:  

Keywords:  C-reactive protein; Erythrocyte sedimentation rate; Inflammation; Physical examination; Rheumatoid arthritis; Synovitis

Mesh:

Substances:

Year:  2016        PMID: 27882446     DOI: 10.1007/s10067-016-3482-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

Review 1.  Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice.

Authors:  Hisashi Yamanaka; Shigeto Tohma
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

2.  Weighting for joint surface area improves the information provided by a reduced 28-joint articular index of swollen joints.

Authors:  G Stucki; O Sangha; P Brühlmann; S Stucki; B A Michel
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

3.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

4.  Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response.

Authors:  P W Thompson; A J Silman; J R Kirwan; H L Currey
Journal:  Arthritis Rheum       Date:  1987-06

Review 5.  Current treatments of rheumatoid arthritis: from the 'NinJa' registry.

Authors:  Yukihiko Saeki; Toshihiro Matsui; Koichiro Saisho; Shigeto Tohma
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

Review 6.  Fibrinogen gene regulation.

Authors:  Richard J Fish; Marguerite Neerman-Arbez
Journal:  Thromb Haemost       Date:  2012-07-26       Impact factor: 5.249

7.  Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.

Authors:  Tuulikki Sokka; Theodore Pincus
Journal:  J Rheumatol       Date:  2009-05-01       Impact factor: 4.666

8.  American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

Authors:  D T Felson; J J Anderson; M Boers; C Bombardier; D Furst; C Goldsmith; L M Katz; R Lightfoot; H Paulus; V Strand
Journal:  Arthritis Rheum       Date:  1995-06

9.  Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.

Authors:  Jonathan Kay; Olga Morgacheva; Susan P Messing; Joel M Kremer; Jeffrey D Greenberg; George W Reed; Ellen M Gravallese; Daniel E Furst
Journal:  Arthritis Res Ther       Date:  2014-02-03       Impact factor: 5.156

10.  CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients.

Authors:  Christian Gytz Ammitzbøll; Rudi Steffensen; Martin Bøgsted; Kim Hørslev-Petersen; Merete L Hetland; Peter Junker; Julia S Johansen; Jan Pødenphant; Mikkel Østergaard; Torkell Ellingsen; Kristian Stengaard-Pedersen
Journal:  Arthritis Res Ther       Date:  2014-10-31       Impact factor: 5.156

View more
  2 in total

1.  Correlation of CRP genotypes with serum CRP levels and the risk of rheumatoid arthritis in Chinese Han population.

Authors:  Shanshan Liu; Ju Li; Yongsheng Li; Yan Liu; Kai Wang; Wenyou Pan
Journal:  Clin Rheumatol       Date:  2022-07-28       Impact factor: 3.650

2.  How to Differentiate Gout, Calcium Pyrophosphate Deposition Disease, and Osteoarthritis Using Just Four Clinical Parameters.

Authors:  Dmitrij Kravchenko; Raoul Bergner; Charlotte Behning; Valentin Sebastian Schäfer
Journal:  Diagnostics (Basel)       Date:  2021-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.